Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGM-CSF capsule for chemotherapy-induced leukopenia (phase II)
CTR20150133Phase 2Active
- Sponsor
- Zhejiang Zhongqi Pharmaceutical
- Start
- Mar 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of granulocyte macrophage-colony stimulating factor in chemotherapy-induced leukopenia (CIL), sponsored by Zhejiang Zhongqi Pharmaceutical. Started Mar 2015; status: active.
02
Drugs
granulocyte macrophage-colony stimulating factor
03
Conditions
chemotherapy-induced leukopenia (CIL)
Beyond the preview
Go deeper on CTR20150133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150133.